Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

Groopman, Jerome E.; Gottlieb, Michael S.; Goodman, Jesse; Mitsuyasu, Ronald T.; Conant, Marcus A.; Prince, Harry; Fahey, John L.; Derezin, Marvin; Weinstein, Wilfred M.; Casavante, Conrad; Rothman, John; Rudnick, Seth A.; Volberding, Paul A.; Groopman, J E; Gottlieb, M S; Goodman, J; Mitsuyasu, R T; Conant, M A; Prince, H; Fahey, J L
May 1984
Annals of Internal Medicine;May84, Vol. 100 Issue 5, p671
Academic Journal
journal article
In a randomized prospective study we tested the toxicity and efficacy of recombinant alpha-2 interferon in the treatment of Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. High doses (50 X 10(6) U/m2 body surface area, intravenously) or low doses (1 X 10(6) U/m2, subcutaneously) of recombinant alpha-2 interferon were administered to 20 patients for 5 days/wk, every other week, for four treatment cycles. Therapy was well tolerated subjectively and caused only mild hematologic and hepatic toxicity at both dose levels. No consistent or sustained changes were seen in immunologic variables during or after treatment. Six patients with Kaposi's sarcoma, four at high dose and two at low dose, had objective responses (complete or partial) to treatment. However, therapy did not appear to eradicate cytomegalovirus carriage or prevent opportunistic infections related to cytomegalovirus.


Related Articles

  • Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. Oranje, Arnold P.; Chosidow, Olivier; Sacchidanand, Sarvajnamurthy; Todd, Gail; Singh, Krishan; Scangarella, Nicole; Shawar, Ribhi; Twynholm, Monique; TOC100224 Study Team // Dermatology (10188665);Dec2007, Vol. 215 Issue 4, p331 

    Background: Retapamulin is a novel pleuromutilin antibacterial developed for topical use. Objective: To compare the efficacy and safety of retapamulin ointment, 1% (twice daily for 5 days), with sodium fusidate ointment, 2% (3 times daily for 7 days), in impetigo....

  • Use of misoprostol on an outpatient basis for postdate pregnancy Kipikasa, J.H.; Adair, C.D.; Williamson, J.; Breen, J.M.; Medford, L.K.; Sanchez-Ramos, L. // International Journal of Gynecology & Obstetrics;Feb2005, Vol. 88 Issue 2, p108 

    Objective: Within the obstetric community, several studies suggest that cervical ripening and labor induction after 40 weeks' gestation leads to improved maternal and neonatal outcomes. The most effective drug regimen to safely promote labor has not been determined.Method:...

  • Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis. Zuberbier, Torsten; Heinzerling, Lucie; Bieber, Thomas; Schauer, Uwe; Klebs, Sven; Bräutigam, Matthias; Bräutigam, Matthias // Dermatology (10188665);Dec2007, Vol. 215 Issue 4, p325 

    Objective: To investigate if pimecrolimus cream 1% reduces the need for steroids in the long-term management of severe pediatric atopic dermatitis (AD).Methods: A total of 184 pediatric patients (aged 2-17 years) with a history of severe AD according to Rajka and...

  • Intracervical misoprostol and prostaglandin E2 for labor induction Chang, Y.-K.; Chen, W.-H.; Yu, M.-H.; Liu, H.-S. // International Journal of Gynecology & Obstetrics;Jan2003, Vol. 80 Issue 1, p23 

    Objectives: To compare the safety and efficacy of misoprostol with PGE2 for induction of labor by intracervical administration. Methods: Eighty-six women with indications for labor induction at term were randomly assigned to two groups. Each woman received either 50 μg of misoprostol or 0.5...

  • Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study. van Bezooijen, Ji Sun; Balak, Deepak M.W.; van Doorn, Martijn B.a.; Looman, Caspar W.N.; Schreurs, Marco W.J.; Koch, Birgit C.P.; van Gelder, Teun; Prens, Errol P. // Dermatology (10188665);Sep2016, Vol. 232 Issue 4, p407 

    Background: Biologics are a safe and efficacious therapy for psoriasis. The drug survival of biologics may be disappointing, primarily due to loss of efficacy. Therefore, safe combination treatments are sought to improve their clinical response.Objective: To assess the...

  • Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Stacher, Georg; Abatzi-Wenzel, Thalia-Anthi; Wiesnagrotzki, Stefan; Bergmann, Helmar; Schneider, Christa; Gaupmann, Gabriele; Stacher, G; Abatzi-Wenzel, T A; Wiesnagrotzki, S; Bergmann, H; Schneider, C; Gaupmann, G // British Journal of Psychiatry;Mar93, Vol. 162, p398 

    In a double-blind trial, 12 out-patients with primary anorexia nervosa received, for six weeks, either 10 mg cisapride or placebo, three times a day. Cisapride accelerated gastric emptying of a radiolabelled semisolid meal in all six patients; five gained weight and symptoms of gastric retention...

  • Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial. Campanati, anna; Giannoni, Melania; Scalise, alessandro; De Blasio, Simona; Giuliano, angela; Giuliodori, Katia; Ganzetti, Giulia; Bolletta, Elisa; Di Benedetto, Giovanni; Offidani, annamaria // Dermatology (10188665);Sep2016, Vol. 232 Issue 4, p478 

    Background/objective: This study aims at the evaluation of the efficacy and safety of a combination therapy based on pidobenzone 4% and fractional CO2 laser or cryotherapy in the treatment of solar lentigines and the prevention of eventual posttreatment hyperchromia.Methods:...

  • Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping. Beck, Hans-Peter; Wampfler, Rahel; Carter, Nick; Koh, Gavin; Osorio, Lyda; Rueangweerayut, Ronnatrai; Krudsood, Srivcha; Lacerda, Marcus V.; Llanos-Cuentas, Alejandro; Duparc, Stephan; Rubio, Justin P.; Green, Justin A. // Journal of Infectious Diseases;3/1/2016, Vol. 213 Issue 5, p794 

    Unlabelled: Prevention of relapse of Plasmodium vivax infection is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled phase 2b study in Peru, India, Thailand, and Brazil allowed determination of genetically...

  • A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis Köhler, Günter; Faustmann, Thomas A.; Gerlinger, Christoph; Seitz, Christian; Mueck, Alfred O.; Köhler, Günter // International Journal of Gynecology & Obstetrics;Jan2010, Vol. 108 Issue 1, p21 

    Objectives: To compare the efficacy and safety of dienogest at doses of 1, 2, and 4mg/day orally in the treatment of endometriosis.Methods: An open-label, randomized, multicenter, 24-week comparative trial in women with histologically confirmed endometriosis. Efficacy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics